C.H. Robinson to buy RXO for $5.8 billion
CHRW•C.H. Robinson said it would buy RXO in a stock-and-cash transaction valued at $5.8 billion. RXO stockholders would receive $17.25 per share in cash and 0.0856 C.H. Robinson shares; the deal is expected to close in the first half of 2027, subject to regulatory and stockholder approval.
1. Deal terms
C.H. Robinson said it would buy RXO in a stock-and-cash transaction valued at $5.8 billion. RXO stockholders would receive $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock.
2. Expected closing
The deal is expected to close in the first half of 2027, subject to regulatory and RXO stockholder approval.
Related News
TuHURA Biosciences receives U.S. patent for delta opioid receptor antibody drug conjugate technology
HURA•
Fortive Corporation: Truist Securities cuts target price to $63 from $68
FTV•
